REGULATORY STATUS
Current framework
The published transition framework provides for compliance with the amended labelling requirements from June 22, 2028.
Proposed changes
Health Canada is targeting draft amendments for spring 2027, including more flexible labelling and a proposed transition beyond June 2028. The revised timeline is to be determined through consultation.
We separate current obligations from proposed changes so your team can plan before committing to artwork and print.
Reviewed: September 23, 2026.
WHAT THE REVIEW COVERS
The amended labelling framework addresses the Product Facts Table, legibility, priority-allergen information, and modernized contact details. Our review starts with the information behind the artwork. We reconcile product licence details, ingredient information, supplier declarations, and bilingual wording before assessing how the content fits the package.
Product information
Licence-to-label alignment, ingredients, directions, warnings, and storage.
Declarations
Supplier-backed information supporting applicable allergen and other statements.
Layout and readability
Product Facts Table presentation, typography, contrast, and packaging constraints.
Contact information
Appropriate contact details and consistency with associated product information.
DECISION PLANNING
Not every SKU needs the same decision at the same time. We distinguish current compliance issues from transition preparation and identify which packaging decisions should be revisited before production.
Fix now
Review current licence-to-label discrepancies, inaccurate product information, and existing compliance issues.
Prepare now
Assemble approved bilingual content, supplier declarations, packaging dimensions, editable artwork, and inventory data.
Reassess before print
Confirm the applicable requirements and the status of proposed changes before approving major packaging changes or long print runs.
The result is a SKU-level action plan with priorities, responsibilities, and clear review points.
CONTROLLED CONTENT
Your package, website, and retailer listings should draw from controlled product information. We help reconcile the content, document approvals, and identify where each change needs to be carried through.
Product identity, NPN or DIN-HM, and relevant licence information.
Medicinal and non-medicinal ingredient details.
Approved uses, directions, warnings, and storage instructions.
Applicable allergen and other declaration information.
Reviewed English and French wording.
Artwork versions, approval dates, and associated online content.
A practical content-control process can support both the current label and future updates.
PACKAGING FEASIBILITY
We assess whether your existing packaging can support the applicable information before recommending a larger label or a new container. Where changes are needed, we compare practical options with your design and production teams.
Available label area and container dimensions.
English/French layout and proofing.
Product Facts Table requirements and applicable flexibilities.
Inner and outer packaging considerations.
Alternative label or packaging concepts where appropriate.
Readability, print feasibility, and operational impact.
Product Facts Table exemptions and formatting flexibilities are conditional and must be assessed for the specific product and package.
Packaging feasibility review
Unbranded supplement bottles in different sizes, a neutral carton, flat label mockups, and measuring tools on a warm ivory review desk.
Assess the available space before committing to a packaging change.
Connected product information
An unbranded supplement bottle beside a smartphone showing a simple illustrative bilingual information layout, with restrained navy and cream styling.
Connect packaging and digital information through controlled content.
DIGITAL READINESS
Prepare your product information for digital use while respecting what must remain on the package. We assess the current options and build a controlled content structure that can adapt as requirements evolve.
Assess what must remain physically on-pack.
Review eligibility for existing information-placement flexibilities.
Plan bilingual, mobile-readable supplementary information.
Establish stable URLs, approval records, and version control.
Define responsibilities for link and content maintenance.
Identify decisions to revisit when proposed changes are finalized.
Current guidance permits electronic Product Facts Tables under specified conditions, but an ePFT does not replace the physical PFT. Health Canada is also exploring enhanced digital labelling through its proposed changes.
TRANSITION PLANNING
Build a SKU-by-SKU transition plan around inventory, production lead times, and the requirements that apply at the time. We identify priority changes and decision points before you commit to new printed stock.
Inventory : Finished goods, unused labels, cartons, and work in progress.
Commercial timing : Sales velocity, replenishment, seasonal demand, and retailer requirements.
Production timing : Print quantities, minimum orders, artwork approval, and manufacturing lead times.
Controlled rollout : Approved artwork versions, review checkpoints, and identification of old and new stock.
Portfolio transition planning
An organized packaging-planning workspace with unbranded cartons, label rolls, a navy project folder, and a simple production-planning sheet without readable confidential information.
Coordinate artwork, inventory, and production before the next print run.
WAYS TO WORK TOGETHER
Portfolio Readiness Review
Assess your SKU range, reconcile current information, identify packaging constraints, and prioritize next steps.
Label Transition Project
Develop controlled bilingual content, coordinate artwork, review proofs, and plan implementation.
Ongoing Label Change Support
Maintain product information and assess regulatory, ingredient, supplier, and packaging changes within an agreed scope.
Start with your current labels, product licence information, SKU list, and expected next print date. We will help identify what needs attention now and what should be reviewed before your next production commitment.